Early Detection of chemotherapy Induced Cardiotoxicity by Cardiac Magnetic Resonance

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034807

Enrollment

Unknown

Registered

2020-07-20

Start date

2020-08-10

Completion date

Unknown

Last updated

2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac toxicity

Interventions

Normal group:N

experimental group 1:Chemotherapy

experimental group 2:Targeted treatment

experimental group:Immunotherapy

Eligibility

Sex/Gender

All

Age

17 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.The patient needs to be diagnosed as a malignant tumor (not involving the heart) by pathology. 2.The patient had normal blood routine, liver and kidney function, and cardiac function, and no contraindication to chemotherapy. 3.Sign the informed consent. 4.Patients who meet the screening protocol.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications of MRI examination; 2. Patients with structural heart disease, valvular disease and cardiomyopathy; 3. Those who have history of arrhythmia.

Design outcomes

Primary

Measure	Time frame
Left ventricular function;T1 mapping;ECV;Left ventricular size;	—

Countries

China

Contacts

Public ContactXuegong Shi

The First Affiliated Hospital of Anhui Medical University

shixgay@sohu.com+86 13855171977

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026